| NCT ID | NCT06831110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Iowa |
| Condition | Aquagenic Wrinkling of Palms |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-03-06 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-03-06 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrinkling procedure to see how their hands respond.
Eligibility Criteria
Inclusion Criteria: * Interested in participating in other CF Carrier-related research studies. Exclusion Criteria: * CF patient status * Unable to speak English * Unable to provide written informed consent * Prisoner status * An open wound on either hand * A tattoo on either hand * Missing any portion of either hand * Diagnosis of Diabetes * Diagnosis of Hyperhidrosis * Diagnosis of Raynaud's Disease * Diagnosis of Atopic Dermatitis * Regularly taking ACE inhibitors or angiotensin receptor blockers
Contact & Investigator
Philip M Polgreen, MD
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT06831110 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 24 Years, studying Aquagenic Wrinkling of Palms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06831110 currently recruiting?
Yes, NCT06831110 is actively recruiting participants. Contact the research team at philip-polgreen@uiowa.edu for enrollment information.
Where is the NCT06831110 trial being conducted?
This trial is being conducted at Iowa City, United States.
Who is sponsoring the NCT06831110 clinical trial?
NCT06831110 is sponsored by University of Iowa. The principal investigator is Philip M Polgreen, MD at University of Iowa. The trial plans to enroll 2,000 participants.